CM Management’s Cytokinetics CYTK Stock Holding History

CM Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,000	Closed	-$1.61M	–	70
2025 Q1	$1.61M	Buy	+40,000	New	+$1.84M	1.62%	29
2023 Q3	–	Sell	-10,000	Closed	-$326K	–	71
2023 Q2	$326K	Sell	10,000 -25,000	-71%	-$925K	0.32%	61
2023 Q1	$1.23M	Sell	35,000 -15,000	-30%	-$612K	1.46%	24
2022 Q4	$2.29M	Hold	50,000	–	–	2.74%	13
2022 Q3	$2.42M	Sell	50,000 -50,000	-50%	-$2.41M	2.7%	10
2022 Q2	$3.93M	Sell	100,000 -120,000	-55%	-$4.83M	4.18%	4
2022 Q1	$8.1M	Sell	220,000 -55,000	-20%	-$1.95M	6.8%	1
2021 Q4	$12.5M	Hold	275,000	–	–	9.47%	1
2021 Q3	$9.83M	Sell	275,000 -50,000	-15%	-$1.47M	7.33%	1
2021 Q2	$6.43M	Hold	325,000	–	–	4.65%	2
2021 Q1	$7.56M	Hold	325,000	–	–	5.62%	1
2020 Q4	$6.75M	Buy	+325,000	New	+$5.94M	6.26%	1

Other funds holding CYTK

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return